IBACNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBACR
IB Acquisition Corp.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.86+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
IB Acquisition has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements IB Acquisition filed with the SEC
Acquisition Corp. Announces Date of 2026 Annual Meeting of Stockholders
Other events · EX-99.1 to Form 8-K
Insilico Inc. to go Public Through Business Combination With IB Acquisition Corp. (NASDAQ: IBAC)
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
Acquisition Corp. Announces Upcoming Automatic Unit Separation
Other events · EX-99.1 to Form 8-K
Report of Independent Registered Public Accounting Firm (PCAOB #1195)
Other events · EX-99.1 to Form 8-K
Acquisition Corp. Announces Pricing of $100,000,000 Initial Public Offering
Material agreement · Unregistered share sale · Executive or director change · Other events · EX-99.1 to Form 8-K
Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering, Including Full Exercise of Underwriter Over-Allotment Option
Material agreement · Unregistered share sale · Executive or director change · Other events · EX-99.2 to Form 8-K